Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0724-2026

Cepheid recalls Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.

CepheidSunnyvale, CA, United StatesReported Dec 3, 2025 · 7 months ago
Legal News Analyst ·

Reason for recall

Product testing did not meet expected stability criteria.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Xpert MTB/RIF. Model Number:GXMTB/RIF-US-10
    UDI-DI 07332940000912.Model Number
    2 affected lots
    413022025-02-02

What the firm is doing

Cephid notified consignees on about 11/05/2025 via FedEx letter. Consignees were instructed to ensure no affected units remain in inventory or are available for use since the affected lots have passed their expiration date. Past results obtained from Xpert MTB/RIF batch 1000812229 lot 41302 may be inaccurate. If these results were used to make clinical management decisions, it is recommended that the results be reviewed in the context of corresponding culture data, drug susceptibility testing, clinical presentation and other relevant laboratory information to ensure accurate patient care. If there is uncertainty or insufficient information to confirm the result, repeat testing to ensure accuracy. Consignees were requested to notify relevant clinical teams as needed. Cepheid will provide products for the purposes of retesting. Kits are expected to ship within 5 business days following receipt of the completed response form. Additionally, consignees were instructed to complete and return the Customer Response Form.

DistributionShow details

US Nationwide distribution and Puerto Rico.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls